UPSHER-SMITH 200 mg (Qudexy XR 200 mg)
Generic Name: topiramate
Pill with imprint UPSHER-SMITH 200 mg is Brown / Gray, Capsule-shape and has been identified as Qudexy XR 200 mg. It is supplied by Upsher-Smith Laboratories, Inc..
Qudexy XR is used in the treatment of epilepsy; lennox-gastaut syndrome; migraine prevention; seizure prevention; seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Qudexy XR 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for UPSHER-SMITH 200 mg
- Generic Name
- UPSHER-SMITH 200 mg
- 200 mg
- Brown / Gray
- Prescription only
- Drug Class
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Upsher-Smith Laboratories, Inc.
Labelers / Repackagers
|NDC Code||Labeler / Repackager|
|00245-1073||Upsher-Smith Laboratories Inc.|
|00832-1073||Upsher-Smith Laboratories Inc.|
Related Images for "UPSHER-SMITH 200 mg"
More about Qudexy XR (topiramate)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 5 Reviews
- Generic Availability
- Drug class: carbonic anhydrase inhibitor anticonvulsants
- FDA Alerts (3)
- FDA Approval History
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.